The-Huan Tran

Computational discovery and dynamic profiling of dual acetylcholinesterase and monoacylglycerol lipase inhibitors for Alzheimer's disease.

Compound H34 is highlighted as a promising dual-target candidate for Alzheimer's disease therapy and illustrates the effectiveness of integrated computational strategies in early-stage drug discovery.